Observational Study to Investigate the Efficacy and Safety of Human Insulin or Insulin Analogue Treatments in Type 2 Diabetes Subjects

Inclusion Criteria: * After the investigator has taken the decision to use human insulin or insulin analogues to treat the subject, any type 2 diabetic previously inadequately controlled with two or more OADs is eligible for the study * The selection of the subjects will be at the discretion of the individual investigator Exclusion Criteria: * Known or suspected allergy to trial product(s) or related products * Subjects who are unlikely to comply with protocol requirements, e.g. uncooperative attitude, inability to return for the final visit * Subjects who previously enrolled in this study * Females of childbearing potential who are pregnant, breast-feeding or intend to become pregnant or are not using adequate contraceptive methods * The receipt of any investigational product within 3 months prior to this trial